Open App
Nuclera is bettering human health by making proteins accessible. Headquartered in Cambridge, UK with significant operations in Boston, MA, Nuclera's 120-strong team is achieving its mission through the eProtein Discovery system. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges to enable rapid progress on projects gated by protein access through a high-throughput, automated benchtop protein prototyping system. With our technology, we empower researchers to rapidly access, prototype, and de-risk target proteins to accelerate drug discovery.
